XDH and hyperuricemia: Gao et al. synthesized new molecules with the 3‐[4‐alkoxy‐3‐(1H‐tetrazol‐1‐yl)phenyl]‐1,2,4‐oxadiazol‐5(4H)‐ones skeleton as possible XO inhibitors for the treatment of hyperuricemia and gout.